41 results
8-K
EX-99.1
OMIC
Singular Genomics Systems Inc
14 May 24
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
4:06pm
share and per share amounts)
Three Months Ended March 31,
Revenue
Cost of revenue
Gross margin
Operating expenses:
Research and development
Selling
PRE 14A
OMIC
Singular Genomics Systems Inc
5 Apr 24
Preliminary proxy
4:30pm
technical strategic programs with large multi-functional teams. Prior to Roche, Dr. Ghai served as the Vice President of Research and Development, Biosurgery
8-K
EX-99.1
x3twgjk8rro4xvd lk
18 Mar 24
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
EX-99.1
plq1ucyj8t
14 Nov 23
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
ucumclq8
9 Aug 23
Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
4:04pm
8-K
EX-99.1
0pytojssf klb7u759cy
9 May 23
Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results
4:04pm
8-K
EX-99.1
ng69n0z6zigj2dsq
7 Nov 22
Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results
4:01pm
8-K
EX-99.1
vc4lbj6wyth65j mf
9 Aug 22
Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results
12:00am
S-3
EX-1.2
dnk23ts3zg5qilpjk
19 Jul 22
Shelf registration
4:16pm
8-K
EX-99.1
6c33lb6omp9
10 May 22
Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results
4:10pm